Sympercent change in KIM-1 from EV preinfusion to postinfusion predicted 3-month HTN with an AUC (95% CI) of 0.73 (0.60 to 0.87) (Supplemental Table 4). The gene discussed is HAVCR1; the disease is hypertensive disorder.